I've read on the BBC that the UK is seeking to renegotiate the NI protocol with the EU (which is part of the Brexit deal). I can understand why the UK sees some of the provisions as burdensome, but I'm not sure I see why it seeks to "remove medicines entirely from the scope of the protocol". Medicines are among the most controlled things on earth in terms of imports/exports and general paperwork involved anywhere, even internally in a country. It's also not the case that they are manufactured by a mom-and-pop business that can't afford a compliance department. So I'm not sure why the UK thinks medicines in particular are extraordinarily burdened by NI protocol provisions. Can someone explain, preferably with the UK's own talking points?
Create | Share | Influence